Home > Browse Research > Life Sciences > Pharmaceuticals > Therapeutic Area > CNS/Neurology

CNS/Neurology: market research reports

CNS/Neurology market research reports and industry analysis

Brain Cancer – Pipeline Review, H1 2013 2/28/2013 \| published by: Global Markets Direct ... Brain Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Brain Cancer. Brain Cancer - Pipeline Review, Half Year is ... \| read more...	$2,000.00
Substance (Drug) Abuse – Pipeline Review, H1 2013 2/28/2013 \| published by: Global Markets Direct ... development for Substance (Drug) Abuse, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Substance (Drug) Abuse. Substance (Drug) Abuse - ... \| read more...	$2,000.00
Brain Metastasis – Pipeline Review, H1 2013 2/28/2013 \| published by: Global Markets Direct ... Brain Metastasis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Brain Metastasis. Brain Metastasis - Pipeline Review, Half Year is ... \| read more...	$2,000.00
Brain Monitoring Market [By Product [EEG/Magnetoencephalography (MEG)/ Intracranial Pressure Monitor/Cerebral Oximeter/ Transcranial Doppler] & Application [Sleep Disorders/ Epilepsy/Traumatic Brain Injury/Brain Death] – Global Forecasts to 2017 2/11/2013 \| published by: MarketsandMarkets ... brain monitoring devices (electroencephalograph, intracranial pressure monitors, Transcranial Doppler, magnetoencephalography, and cerebral oximeters ), which help in monitoring a range of functions, such as electrical and neural activity, pressure surrounding the brain, velocity of blood ... \| read more...	$4,650.00
Intraoperative Neuromonitoring Market in the US 2012-2016 2/4/2013 \| published by: Infiniti Research Limited ... patient population with various neurological disorders. The Intraoperative Neuromonitoring market in the US has also been witnessing the trend of increasing mergers and acquisitions. However, the highly fragmented market could pose a challenge to the ... \| read more...	$2,000.00
CNS Therapeutics 2/1/2013 \| published by: Global Industry Analysts ... Sclerosis, Insomnia and ADHD). The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. The ... \| read more...	$4,950.00
Cellular Therapy and Cord Blood 2013 Market Report 2/1/2013 \| published by: Select Biosciences Limited ... order to characterize the growth and evolution of the cellular therapy field--in this vein, we present primary industry data that Select Biosciences has collected as part of its continual industry tracking of this space. We've ... \| read more...	$2,185.00
Amyotrophic Lateral Sclerosis – Analysis and Market Forecasts to 2019 1/31/2013 \| published by: GlobalData ... essential source of information and analysis on the global Amyotrophic Lateral Sclerosis Therapeutics market. The report identifies the key trends shaping and driving the global Amyotrophic Lateral Sclerosis Therapeutics market. The report also provides insights ... \| read more...	$5,995.00
Analysis of the U.S. Neurostimulation Market 1/24/2013 \| published by: Frost & Sullivan ... technological advances, and pricing analyses are provided for the market’s various segments including: spinal cord stimulators, deep brain stimulators, vagus nerve stimulators, and sacral nerve stimulators. Furthermore, market engineering measurements, industry challenges, drivers, restraints, company ... \| read more...	$6,000.00
Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) – Forecasts from 2012 to 2017 1/14/2013 \| published by: MarketsandMarkets ... science is evolving for analyzing the basic metabolic changes taking place in a living organism. Metabolomics is thus an emerging concept which refers to the systematic study of the distinctive chemical fingerprints generated in a ... \| read more...	$4,650.00
The 2013-2018 Outlook for Psychotherapeutic Tranquilizing Agents Excluding Phenothiazine Derivatives in the United States 1/9/2013 \| published by: Icon Group International, Inc. ... (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city is of it’s state and of the United States is reported. These comparative ... \| read more...	$495.00
The 2013-2018 Outlook for Antidepressant Pharmaceuticals in the United States 1/9/2013 \| published by: Icon Group International, Inc. ... across some 12,700 cities in the United States. For each city in question, the percent share the city is of it’s state and of the United States is reported. These comparative benchmarks allow the reader ... \| read more...	$495.00
The 2013-2018 World Outlook for Antidepressant Pharmaceuticals- 1/7/2013 \| published by: Icon Group International, Inc. ... or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to ... \| read more...	$795.00
Opioids Market to 2018 - Increasing Concentration of Abuse-Resistant Branded Generics Alter Competitive Dynamics in this Flat Market 1/4/2013 \| published by: GBI Research ... 2018 - Increasing Concentration of Abuse-Resistant Branded Generics Alter Competitive Dynamics in this Flat Market”. The current opioids market is characterized by a very broad and highly diversified product portfolio. Patients experiencing moderate to severe ... \| read more...	$3,500.00
Neurology and Neurosurgery 1/1/2013 \| published by: Apollo Managed Care, Inc. ... criteria guidelines for outpatient and inpatient tests and procedures with indications, medical necessity coverage criteria, authoritative references and resources ++ Alzheimer disease & ADHD page clinical guidelines - both with extensive references and resource materials. \| read more...	$149.00
Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2012 12/28/2012 \| published by: GlobalData ... provides elemental information and data relating to the clinical trials on Glioblastoma Multiforme (GBM). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the ... \| read more...	$2,500.00
Astrocytoma Global Clinical Trials Review, H2, 2012 12/28/2012 \| published by: GlobalData ... to the clinical trials on Astrocytoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of ... \| read more...	$2,500.00
EpiCast Report: Epilepsy Epidemiology Forecast to 2022 12/28/2012 \| published by: GlobalData ... a collection of brain dysfunction disorders characterized by recurrent and unpredictable seizures. The prevalence of epilepsy varies among countries due to a mosaic of economic, political, and social differences. GlobalData epidemiologists expect that the number ... \| read more...	$3,995.00
Addiction – Pipeline Review, H2 2012 12/26/2012 \| published by: Global Markets Direct ... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Addiction. Addiction - Pipeline Review, Half Year is built using data and information ... \| read more...	$2,000.00
Dementia – Pipeline Review, H2 2012 12/26/2012 \| published by: Global Markets Direct ... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dementia. Dementia - Pipeline Review, Half Year is built using data and information ... \| read more...	$2,000.00
Nicotine Addiction – Pipeline Review, H2 2012 12/26/2012 \| published by: Global Markets Direct ... Nicotine Addiction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Nicotine Addiction. Nicotine Addiction - Pipeline Review, Half Year is ... \| read more...	$2,000.00
Brain Injury – Pipeline Review, H2 2012 12/26/2012 \| published by: Global Markets Direct ... Brain Injury, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Brain Injury. Brain Injury - Pipeline Review, Half Year is ... \| read more...	$2,000.00
Anxiety Disorders – Pipeline Review, H2 2012 12/26/2012 \| published by: Global Markets Direct ... Anxiety Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Anxiety Disorders. Anxiety Disorders - Pipeline Review, Half Year is ... \| read more...	$2,000.00
Research Report on China's Antidepressant Market, 2013-2017 12/26/2012 \| published by: China Research and Intelligence Co., Ltd. ... million people commit suicide every year because of depression. Depression becomes a health crisis worldwide. Depression (also DEP) is a set of mood disorders or affective disorders with the main symptom of depression caused by ... \| read more...	$2,800.00
Seizures – Pipeline Review, H2 2012 12/26/2012 \| published by: Global Markets Direct ... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Seizures. Seizures - Pipeline Review, Half Year is built using data and information ... \| read more...	$2,000.00

< prev 1 2 3 4 5 6 7 8 9 10 next >